- Home
- TIL vs STKS Comparison
TIL vs STKS Comparison
Compare TIL & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | STKS |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.7M | 74.3M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | TIL | STKS |
|---|---|---|
| Price | $8.66 | $1.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $125.00 | $4.50 |
| AVG Volume (30 Days) | 30.4K | ★ 31.2K |
| Earning Date | 03-03-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.54 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $805,722,000.00 |
| Revenue This Year | N/A | $23.94 |
| Revenue Next Year | N/A | $5.93 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 19.66 |
| 52 Week Low | $5.67 | $1.66 |
| 52 Week High | $42.75 | $5.19 |
Technical Indicators
Market Signals| Indicator | TIL | STKS |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 42.32 |
| Support Level | $8.14 | $1.70 |
| Resistance Level | $9.27 | $2.08 |
| Average True Range (ATR) | 0.48 | 0.13 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 40.90 | 35.71 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.